GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (FRA:65G) » Definitions » Total Equity

NextCell Pharma AB (FRA:65G) Total Equity : €5.14 Mil (As of Nov. 2024)


View and export this data going back to 2020. Start your Free Trial

What is NextCell Pharma AB Total Equity?

NextCell Pharma AB's total equity for the quarter that ended in Nov. 2024 was €5.14 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


NextCell Pharma AB Total Equity Historical Data

The historical data trend for NextCell Pharma AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Total Equity Chart

NextCell Pharma AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.54 14.70 10.99 6.41 5.90

NextCell Pharma AB Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.71 4.96 4.05 5.90 5.14

NextCell Pharma AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

NextCell Pharma AB's Total Equity for the fiscal year that ended in Aug. 2024 is calculated as

Total Equity=Total Assets(Q: Aug. 2024 )-Total Liabilities(Q: Aug. 2024 )
=7.096-1.195
=5.90

NextCell Pharma AB's Total Equity for the quarter that ended in Nov. 2024 is calculated as

Total Equity=Total Assets(Q: Nov. 2024 )-Total Liabilities(Q: Nov. 2024 )
=5.985-0.842
=5.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NextCell Pharma AB Total Equity Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB Headlines

No Headlines